182 related articles for article (PubMed ID: 37279832)
21. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
[TBL] [Abstract][Full Text] [Related]
22. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.
Nguyen T; Thrift AP; Yu X; Duan Z; El-Serag HB
Am J Gastroenterol; 2017 Jul; 112(7):1049-1055. PubMed ID: 28244499
[TBL] [Abstract][Full Text] [Related]
23. Risk of progression in Barrett's esophagus indefinite for dysplasia: a systematic review and meta-analysis.
Krishnamoorthi R; Mohan BP; Jayaraj M; Wang KK; Katzka DA; Ross A; Adler DG; Iyer PG
Gastrointest Endosc; 2020 Jan; 91(1):3-10.e3. PubMed ID: 31421077
[TBL] [Abstract][Full Text] [Related]
24. Wide-area transepithelial sampling with computer-assisted analysis to detect high grade dysplasia and cancer in Barrett's esophagus: a multicenter randomized study.
van Munster SN; Leclercq P; Haidry R; Messmann H; Probst A; Ragunath K; Bhandari P; Repici A; Munoz-Navas M; Seewald S; Lemmers A; Fernández-Esparrach G; Pech O; Schoon EJ; Kariv R; Neuhaus H; Weusten BLAM; Siersema PD; Correale L; Meijer SL; de Hertogh G; Bergman JJGHM; Hassan C; Bisschops R
Endoscopy; 2023 Apr; 55(4):303-310. PubMed ID: 36150646
[TBL] [Abstract][Full Text] [Related]
25. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
[TBL] [Abstract][Full Text] [Related]
26. Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus.
Thota PN; Kistangari G; Singh P; Cummings L; Hajifathalian K; Lopez R; Sanaka MR
Dig Dis Sci; 2016 Jan; 61(1):247-54. PubMed ID: 26233550
[TBL] [Abstract][Full Text] [Related]
27. Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort.
Song KY; Henn AJ; Gravely AA; Mesa H; Sultan S; Shaheen NJ; Shaukat A; Hanson BJ
Dis Esophagus; 2020 Mar; 33(2):. PubMed ID: 31274147
[TBL] [Abstract][Full Text] [Related]
28. Detection of lesions in dysplastic Barrett's esophagus by community and expert endoscopists.
Schölvinck DW; van der Meulen K; Bergman JJGHM; Weusten BLAM
Endoscopy; 2017 Feb; 49(2):113-120. PubMed ID: 27855466
[No Abstract] [Full Text] [Related]
29. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.
Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218
[TBL] [Abstract][Full Text] [Related]
31. Post-endoscopy Barrett's neoplasia after a negative index endoscopy: a systematic review and proposal for definitions and performance measures in endoscopy.
Desai M; Lieberman D; Srinivasan S; Nutalapati V; Challa A; Kalgotra P; Sundaram S; Repici A; Hassan C; Kaminski MF; Sharma P
Endoscopy; 2022 Sep; 54(9):881-889. PubMed ID: 34979570
[TBL] [Abstract][Full Text] [Related]
32. Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists.
Moole H; Patel J; Ahmed Z; Duvvuri A; Vennelaganti S; Moole V; Dharmapuri S; Boddireddy R; Yedama P; Bondalapati N; Uppu A; Vennelaganti P; Puli S
World J Gastroenterol; 2016 Oct; 22(39):8831-8843. PubMed ID: 27818599
[TBL] [Abstract][Full Text] [Related]
33. Utility of confocal laser endomicroscopy in identifying high-grade dysplasia and adenocarcinoma in Barrett's esophagus: a systematic review and meta-analysis.
Gupta A; Attar BM; Koduru P; Murali AR; Go BT; Agarwal R
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):369-77. PubMed ID: 24535597
[TBL] [Abstract][Full Text] [Related]
34. Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women.
Allen JE; Desai M; Roumans CAM; Vennalaganti S; Vennalaganti P; Bansal A; Falk G; Lieberman D; Sampliner R; Thota P; Vargo J; Gupta N; Moawad F; Bruno M; Kennedy KF; Gaddam S; Young P; Mathur S; Cash B; Spaander M; Sharma P
J Clin Gastroenterol; 2021 Apr; 55(4):321-326. PubMed ID: 32379085
[TBL] [Abstract][Full Text] [Related]
35. Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.
Coleman HG; Bhat SK; Murray LJ; McManus DT; O'Neill OM; Gavin AT; Johnston BT
Am J Gastroenterol; 2014 Apr; 109(4):527-34. PubMed ID: 24589668
[TBL] [Abstract][Full Text] [Related]
36. Influence of body mass index on the prevalence and progression of dysplasia in Barrett's esophagus: a retrospective analysis (.).
Thota PN; Arora Z; Benjamin T; Pagadala M; Lopez R; Sanaka MR
Scand J Gastroenterol; 2016 Nov; 51(11):1288-93. PubMed ID: 27460942
[TBL] [Abstract][Full Text] [Related]
37. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
[TBL] [Abstract][Full Text] [Related]
38. Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis.
Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
Gastroenterology; 2016 Mar; 150(3):599-607.e7; quiz e14-5. PubMed ID: 26619962
[TBL] [Abstract][Full Text] [Related]
39. Novel DNA Methylation Biomarker Panel for Detection of Esophageal Adenocarcinoma and High-Grade Dysplasia.
Yu M; Moinova HR; Willbanks A; Cannon VK; Wang T; Carter K; Kaz A; Reddi D; Inadomi J; Luebeck G; Iyer PG; Canto MI; Wang JS; Shaheen NJ; Thota PN; Willis JE; LaFramboise T; Chak A; Markowitz SD; Grady WM
Clin Cancer Res; 2022 Sep; 28(17):3761-3769. PubMed ID: 35705525
[TBL] [Abstract][Full Text] [Related]
40. Barrett's esophagus, towards improved clinical practice.
Martínez-Domínguez SJ; Lanas Á; Domper-Arnal MJ
Med Clin (Barc); 2022 Jul; 159(2):92-100. PubMed ID: 35606193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
